Source: The Lakeside, OR weather data displayed above is derived from the NOAA (National Oceanic and Atmospheric). Air quality and pollution data is derived from the EPA (United States Environmental Protection Agency).
DUBLIN, June 15, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the 510(k) Premarket Notification Application for the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) has been accepted for filing by the U.S. Food and Drug Administration (FDA).
For distribution only in markets where the Resolute Integrity coronary stent is approved. Not for distribution in the USA or Japan. Â© 2010 Medtronic, Inc. All rights reserved. UC201101792EE. The New Gold Standard in. Drug-Eluting Stents.